Promoted Content
Promoted Content

Overview of Cobicistat

Client Email Product
Cobicistat
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

0

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

  • WHO-GMP
Applications: Primojel® is a superdisintegrant suitable for a variety of tablet & capsule formulations. In higher concentrations, It can act as a dissolution enhancing agent.
More Info on Category: Disintegrants & Superdisintegrants
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP
Technical Specifications: Not Available
  • WHO-GMP
Applications: Primellose® croscarmellose sodium is an effective super-disintegrant ,suitable for a variety of tablet and capsule formulations. It is effective when used intragranular and/or extragranular in granular formulations.
Ingredient(s): Croscarmellose Sodium
More Info on Category: Disintegrants & Superdisintegrants
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP
Technical Specifications: Not Available
  • WHO-GMP
Applications: Orally Disintegrating Tablets/Sachets, Dispersible Tablets, Sachets, Chewable Tablets, Sublingual Tablets
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP. US DMF Type IV filed.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry granulation
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Maize starch and Microcrystalline Cellulose
  • WHO-GMP
Applications: Direct Compression, Dry Granulation
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: For small dose API and large dose API with good compressibility.
  • WHO-GMP
Applications: Binder, Film Former, Opthalmic, Microsphere, OD strip, Gel patches.
Ingredient(s): Polyvinyl Alcohol
Route of Administration (Grade): Oral, Ophthalmic, Microsphere Injectable,Topical
Pharmacopoeia Reference: JPE, USP, EP, ChP (China)
Technical Specifications: Highly purified PVA, Partially hydrolysis, having all viscocity grade from 3cps to 48 cps.
  • WHO-GMP
Applications: Orally Disintegrating Tablets (ODTs) / Sachets, Dispersible Tablets / Sachets, Chewable Tablets, Sublingual Tablets.
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression for pH sensitive APIs
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Light Magnesium Oxide, Sodium Starch Glycolate, Pregelatinized Starch, Maize Starch
  • WHO-GMP
Applications: Direct compression for moisture sensitive APIs
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Colloidal Silicon Dioxide, Povidone K30 and Crospovidone
  • WHO-GMP
Applications: Blend homogeneity even for low dose and micronized API’s, No need of other auxillary excipients
Route of Administration (Grade): Solid Oral
Pharmacopoeia Reference: USP-NF
Technical Specifications: Microcrystalline Cellulose and Colloidal Silicon Dioxide
left grey arrow
right gray arrow
  • TABLET;ORAL - 150MG
  • TABLET;ORAL - 150MG;150MG;200MG;300MG
  • TABLET;ORAL - 150MG;800MG
  • TABLET;ORAL - EQ 300MG BASE;150MG
  • TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
  • TABLET;ORAL - 150MG;800MG;200MG;EQ 10MG BASE
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us